Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005

Ian G Barr, Aeron C Hurt, Pina Iannello, C Tomasov, Nicola Deed, Naomi Komadina

    Research output: Contribution to journalArticleResearchpeer-review

    52 Citations (Scopus)

    Abstract

    The prevention and control of disease caused by seasonal and potential pandemic influenza viruses is currently managed by the use influenza vaccines and antivirals. The adamantanes (amantadine and rimantadine) were the first antivirals licensed for use against influenza A viruses and have been used extensively in some countries. Since the early 2000s increased resistance to these drugs has been reported especially in the A(H3) viruses. In this study we analysed recent human influenza A strains isolated in Australia and regionally for evidence of resistance to adamantanes and found evidence of significant resistant emerging during 2005. (c) 2006 Elsevier B.V. All rights reserved.
    Original languageEnglish
    Pages (from-to)112 - 117
    Number of pages6
    JournalAntiviral Research
    Volume73
    Issue number2
    Publication statusPublished - 2007

    Cite this